caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1578754750

Sangeethapriya DuraiswamyMD

GastroenterologyFrisco, TXI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Sangeethapriya Duraiswamy's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 9 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Laboratory Corporation Of America
Clinical Laboratory · Dallas, TX
60186
John Mulloy
Diagnostic Radiology · Eden Prairie, MN
37102
Park Ventura Endoscopy Center, Llc
Ambulatory Surgical Center · Plano, TX
2239
David Bryant
Anesthesiology · Dallas, TX
1846
Vishnu Kalidindi
Internal Medicine · Frisco, TX
1632
Health Imaging Partners Llc
Independent Diagnostic Testing Facility (IDTF) · Frisco, TX
1540
Chris Stewart
Anesthesiology · Rowlett, TX
1436
Syed Imam
Internal Medicine · Addison, TX
1328
KILARU, NAGAMMA1122
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
447
Unique beneficiaries
—
Total services
490
Distinct HCPCS
7
Medicare payment
$51K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 1,103 Gastroenterology providers in TX — below median (cohort median 699).
QUALITY · MIPS · 2024
Final MIPS score
81.0
Quality
66.5
Cost
71.8
Improvement activities
40.0
Promoting interop.
98.0
Payment adjustment
0.25%
Group
PRESCRIBING · PART D · 2024
Total Rx claims
540
Beneficiaries
—
Total drug cost
$22K
Distinct drugs
11
Brand share
17.8%
Top prescribed drugs
Omeprazole210 claims
Pantoprazole Sodium113 claims
Famotidine47 claims
Sodium, Potassium,mag Sulfates42 claims
Sucralfate22 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$503
Payment records
30
By payment type
Food and Beverage$503